IceCure Medical Ltd. Announces $10 Million Rights Offering to Fund Cryoablation Technology Expansion
IceCure Medical Ltd. has announced a rights offering aimed at raising up to $10 million. The offering will provide holders of the company's ordinary shares as of July 9, 2025, with one subscription right per share. Each right allows the holder to subscribe for 0.1703 of a unit, consisting of an ordinary share and a warrant at $1.00 per unit, or alternatively, a unit with a pre-funded warrant at $0.9999 per unit. The rights must be exercised by July 28, 2025. The company's largest shareholder, Epoch Partner Investments Limited, has committed to participate fully, including any over-subscription, up to $5 million. Proceeds from the offering will be used to repay a $2 million bridge loan from Epoch and for general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: IO18147) on June 25, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。